Betalin Therapeutics

Liberating from Insulin Dependency

Betalin Therapeutics was founded in 2015, is headquartered in Jerusalem, Israel, and has $8.1M in recorded funding across 4 rounds.

Headquarters
Jerusalem
Founded
2015
Business Model
B2B
Total Funding
$8.1M
Last Round
$565K Series AJan 2022
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 2 investors for this company. The full record is or through the API.

About

Betalin Therapeutics is developing a bio-engineered micro-pancreas (EMP) that combines stem-cell-derived insulin-producing cells with a supportive tissue scaffold (micro-organ matrix) to treat diabetes via a single subcutaneous transplant. Licensed from the Hebrew University in 2015 and led by CEO Racheli Ofir, the Israel-based biotech aims to eliminate the lifelong immune suppression and low engraftment rates seen with conventional islet-cell transplants.

Summary

Betalin Therapeutics is a Biotech company based in Jerusalem, Israel, founded in 2015. It has raised $8.1M in total across 4 rounds, most recently a $565K Series A round in Jan 2022. Investors include European Innovation Council Fund and Horizon 2020.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries A2022 (est.)
$565K

Sign up to see all 4 events

Funding: Grant through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Betalin Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/betalin-therapeutics"><img src="https://indexed.vc/api/badge/company/betalin-therapeutics" alt="Betalin Therapeutics on Indexed.vc" width="260" height="76" /></a>